# Compass Health, Inc.

Health Center, MO
Page: https://astrelis.co/providers/health_center/261066  
This twin: https://astrelis.co/providers/health_center/261066.md  
CMS Certification Number (CCN): 261066  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 115,113. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -20.1%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 72. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 11.9%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $170.3M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** -12.1%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Compass Health, Inc. & Affiliates, MO

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state, narrowed by address (FACLAND tier 1+3)).

- FY ending 2025-06-30 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-06-GSAFAC-0000379984
- FY ending 2024-06-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-06-GSAFAC-0000060944
- FY ending 2023-06-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-06-GSAFAC-0000006960

| Line | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 181,432,213 [derived, p.6] | 187,871,501 [derived, p.6] | 146,479,386 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 74,353,049 [derived, p.6] | 57,020,551 [derived, p.6] | 35,739,855 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 6,634,515 [derived, p.6] | 4,106,598 [derived, p.6] | 3,989,919 [derived, p.6] |
| other current assets (Statement of financial position) | 5,343,155 [derived, p.6] | 4,318,297 [derived, p.6] | 4,586,882 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 267,762,932 [extracted, p.6] | 253,316,947 [extracted, p.6] | 190,796,042 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 185,817,879 [derived, p.6] | 170,362,501 [derived, p.6] | 129,268,894 [derived, p.6] |
| other long-term assets (Statement of financial position) | 41,184,419 [derived, p.6] | 35,875,423 [derived, p.6] | 41,542,825 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 494,765,230 [extracted, p.6] | 459,554,871 [extracted, p.6] | 361,607,761 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 76,631,245 [derived, p.7] | 75,520,777 [derived, p.7] | 61,413,268 [derived, p.7] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 8,046,735 [derived, p.7] | 13,976,111 [derived, p.7] | 6,306,610 [derived, p.7] |
| other current liabilities (Statement of financial position) | 6,018,026 [derived, p.7] | 18,086 [derived, p.7] | 350 [derived, p.7] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 90,696,006 [extracted, p.7] | 89,514,974 [extracted, p.7] | 67,720,228 [extracted, p.7] |
| long-term debt and leases (Statement of financial position) | 66,664,851 [derived, p.7] | 68,416,830 [derived, p.7] | 63,869,861 [derived, p.7] |
| other long-term liabilities (Statement of financial position) | 15,093,109 [derived, p.7] | 9,330,326 [derived, p.7] | 11,869,075 [derived, p.7] |
| TOTAL LIABILITIES (Statement of financial position) | 172,453,966 [extracted, p.7] | 167,262,130 [extracted, p.7] | 143,459,164 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | 320,289,763 [derived, p.7] | 290,343,862 [derived, p.7] | 215,777,141 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | 2,021,501 [derived, p.7] | 1,948,879 [derived, p.7] | 2,371,456 [derived, p.7] |
| TOTAL NET ASSETS (Statement of financial position) | 322,311,264 [extracted, p.7] | 292,292,741 [extracted, p.7] | 218,148,597 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 598,297,269 [derived, p.8] | 507,511,234 [derived, p.8] | 381,818,968 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | 11,093,481 [derived, p.8] | 7,607,379 [derived, p.8] | 8,151,140 [derived, p.8] |
| other grants and contracts (Statement of activities) | 24,695,833 [derived, p.8] | 24,137,198 [derived, p.8] | 23,114,773 [derived, p.8] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 1,894,489 [derived, p.8] | 1,701,049 [derived, p.8] | 1,236,352 [derived, p.8] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 635,981,072 [extracted, p.8] | 540,956,860 [extracted, p.8] | 414,321,233 [extracted, p.8] |
| salaries and benefits (Statement of activities) | 478,484,971 [derived, p.8] | 402,478,701 [derived, p.8] | 305,933,362 [derived, p.8] |
| supplies and pharmaceuticals (Statement of activities) | 48,515,763 [derived, p.8] | 40,288,194 [derived, p.8] | 27,681,913 [derived, p.8] |
| purchased and professional services (Statement of activities) | 12,557,685 [derived, p.8] | 13,281,807 [derived, p.8] | 9,548,873 [derived, p.8] |
| occupancy (Statement of activities) | 15,958,845 [derived, p.8] | 13,604,106 [derived, p.8] | 10,427,620 [derived, p.8] |
| depreciation and amortization (Statement of activities) | 19,524,477 [derived, p.8] | 16,360,674 [derived, p.8] | 11,010,332 [derived, p.8] |
| interest (Statement of activities) | 2,043,690 [derived, p.8] | 1,777,696 [derived, p.8] | 1,276,061 [derived, p.8] |
| other expenses (Statement of activities) | 45,397,814 [derived, p.8] | 36,237,304 [derived, p.8] | 26,176,189 [derived, p.8] |
| TOTAL EXPENSES (Statement of activities) | 622,483,245 [extracted, p.8] | 524,028,482 [extracted, p.8] | 392,054,350 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | 13,497,827 [extracted, p.8] | 16,928,378 [extracted, p.8] | 22,266,883 [extracted, p.8] |
| non-operating and other changes (Statement of activities) | 16,520,696 [derived] | 57,215,766 [derived] | 22,338,972 [derived] |
| CHANGE IN NET ASSETS (Statement of activities) | 30,018,523 [extracted, p.9] | 74,144,144 [extracted, p.9] | 44,605,855 [extracted, p.9] |
| net assets, beginning (Statement of activities) | 292,292,741 [extracted, p.9] | 218,148,597 [extracted, p.9] | 173,542,742 [extracted, p.9] |
| net assets, end (Statement of activities) | 322,311,264 [extracted, p.9] | 292,292,741 [extracted, p.9] | 218,148,597 [extracted, p.9] |

| Ratio | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| Days cash on hand | 110 days [plausible] | 135 days [plausible] | 140 days [plausible] |
| Current ratio | 2.95x [plausible] | 2.83x [plausible] | 2.82x [plausible] |
| Operating margin | 2.1% [plausible] | 3.1% [plausible] | 5.4% [plausible] |
| Total margin | 4.7% [plausible] | 13.7% [plausible] | 10.8% [plausible] |
| Patient revenue share | 94.1% [plausible] | 93.8% [plausible] | 92.2% [plausible] |
| Grant dependency | 5.6% [plausible] | 5.9% [plausible] | 7.5% [plausible] |
| Salaries share | 76.9% [plausible] | 76.8% [plausible] | 78.0% [plausible] |
| Days in patient receivables | 45 days [plausible] | 41 days [plausible] | 34 days [plausible] |
| Debt to net assets | 0.23x [plausible] | 0.28x [plausible] | 0.32x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Compass Health, Inc. & Affiliates; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Compass Health, Inc.", https://astrelis.co/providers/health_center/261066, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.